CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials

Jihyun An, Joo Hyun Sohn

Clin Mol Hepatol. 2023;29(Suppl):S268-S275. Published online 2022 December 20 DOI: https://doi.org/10.3350/cmh.2022.0437

Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials

Jihyun An, Joo Hyun Sohn

Clinical and Molecular Hepatology. 2023;29(Suppl):S268-S275

Link1

Link2 Link3

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Amedeo Lonardo, Giovanni Targher

Metabolites. 2021;11(2):73

Link1

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Giovanni Targher

Metabolites. 2020;11(1):22

Link1

Abstracts #300082: Current Therapies in Nonalcoholic Fatty Liver Disease (NAFLD). A Meta-analysis of Randomized Controlled Trials

Emily Wood

Endocrine Practice. 2020;26:5

Link1 Link2

Efficacy of Ursodeoxycholic Acid in Nonalcoholic Fatty Liver Disease: An Updated Meta-Analysis of Randomized Controlled Trials

Wenyue Zhang, Yao Tang, Juan Huang, Hong Ren, Yixuan Yang, Qinbing Yang, Huaidong Hu

. 2019;

Link1 Link2

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano

Hepatology. 2010;52(1):79-104

Link1 Link2

The therapeutic efficacy of fenofibrate in nonalcoholic fatty liver disease a meta-analysis of randomized controlled trials

Yongyong Zhang, San-Qiang Li, Yongliang Jia, Ying Song, Ji-Tian Li, Ping Wang, Xin-Juan Pan

. 2021;

Link1 Link2

Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized controlled trials

Gang Tang, Linyu Zhang, Jie Tao, Zhengqiang Wei

Phytotherapy Research. 2021;35(8):4183-4193

Link1 Link2 Link3

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials

Qianqian Ma, Junzhao Ye, Congxiang Shao, Yansong Lin, Tingfeng Wu, Bihui Zhong

Therapeutic Advances in Endocrinology and Metabolism. 2022;13:204201882211224

Link1 Link2 Link3

The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta‐analyses of randomized controlled trials

Kyuyeon Cho, Seoyeon Park, Ai Koyanagi, Louis Jacob, Dong Keon Yon, Seung Won Lee, Min Seo Kim, Seung Up Kim, Beom Kyung Kim, Jae Il Shin, Lee Smith

Obesity Reviews. 2022;23(9):

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.